TORONTO, July 13, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (“VitalHub” or the “Company”) announced today that it has acquired Buddy Healthcare Ltd Oy (“Buddy Healthcare”), a care coordination platform based in Finland.

多伦多，2026年7月13日（环球电讯社）-- Vitalhub Corp.（TSX:VHI）（OTCQX:VHIBF）（“VitalHub”或“公司”）今日宣布，其已收购芬兰的护理协调平台Buddy Healthcare Ltd Oy（“Buddy Healthcare”）。

Transaction Details

交易详情

VitalHub has acquired Buddy Healthcare for total up-front consideration of €8.6 million, plus potential performance-based consideration. The purchase price paid at closing was composed of a cash payment of €8.3 million, subject to working capital adjustments, and the issuance of 75,000 common shares of VitalHub.

VitalHub 已收购 Buddy Healthcare，总前期对价为 860 万欧元，另加潜在的基于业绩的对价。在交割时支付的购买价款由 830 万欧元的现金支付（须根据营运资本进行调整）以及发行 75,000 股 VitalHub 普通股组成。

The maximum amount payable under the all-cash earnouts is €4.5 million based on the achievement of performance-based targets at the end of the first two calendar years post-acquisition..

根据收购后前两个日历年度末绩效目标的达成情况，全现金盈利支付计划下的最高应付金额为450万欧元。

Overview of Buddy Healthcare

Buddy Healthcare 概述

Established in 2016, Buddy Healthcare is a leading care coordination platform widely used across Europe, including Finland and the UK. The platform digitalizes specialised care pathways, replacing physical notes, phone calls, and unnecessary visits with automated guidance that keeps patients on track and frees up hospital resources.

Buddy Healthcare 成立于2016年，是欧洲广泛使用的领先护理协调平台，业务覆盖芬兰和英国等地。该平台将专科护理路径数字化，以自动化指导取代纸质记录、电话沟通和不必要的就诊，确保患者遵循诊疗计划，同时释放医院资源。

The platform consists of a web-based application for healthcare professionals and a mobile app for patients, enabling hospitals to deliver consistent, high-quality care..

该平台包括一个面向医疗专业人员的基于Web的应用程序和一个面向患者的移动应用程序，使医院能够提供一致的高质量护理。

As at June 30, 2026, Buddy Healthcare had Annual Recurring Revenue

截至2026年6月30日，Buddy Healthcare的年度经常性收入为

(

（

1)

1)

of approximately €2.8 million and is approximately Adjusted EBITDA

约为280万欧元，且约为调整后息税折旧摊销前利润（Adjusted EBITDA）

(

（

2)

2)

breakeven.

盈亏平衡。

Strategic Opportunity

战略机遇

The acquisition establishes a strategic beachhead in the Nordic healthcare market through a well-regarded platform and experienced local management team, who are fully committed to the future development of Buddy Healthcare and other VitalHub solutions.

此次收购通过一个备受认可的平台和经验丰富的本地管理团队，在北欧医疗保健市场建立了战略立足点，该团队全心致力于Buddy Healthcare及其他VitalHub解决方案的未来发展。

The acquisition adds a digital backdoor solution that fills a gap in VitalHub’s existing patient flow suite. Buddy currently has a growing operation and customers in the UK. The combination provides opportunities to accelerate Buddy Healthcare's growth in the UK through VitalHub's existing customer relationships and commercial infrastructure..

此次收购增加了一款数字后门解决方案，填补了 VitalHub 现有患者流程套件中的空白。Buddy 目前在英国拥有不断发展的业务和客户群。此次合并为通过 VitalHub 现有的客户关系和商业基础设施加速 Buddy Healthcare 在英国的增长提供了机遇。

The combined offering is highly strategic and further strengthens VitalHub's position as a provider of mission-critical healthcare software that improves access, coordination, and delivery of care.

此次合并提供的产品组合具有高度战略意义，进一步巩固了 VitalHub 作为关键医疗软件提供商的地位，其软件有助于改善医疗服务的可及性、协调性和交付效率。

“Buddy Healthcare represents a highly strategic addition to the VitalHub platform,” said Dan Matlow, CEO of VitalHub. “We have known Buddy Healthcare for a long time and have been impressed by the team's solution and ability to help hospitals digitize and automate complex care digital pathways across over 23 specialties, improving patient engagement while reducing administrative burden for clinicians.

“Buddy Healthcare 是 VitalHub 平台极具战略意义的补充，”VitalHub 首席执行官 Dan Matlow 表示。“我们与 Buddy Healthcare 相识已久，对其团队提供的解决方案以及帮助医院在超过 23 个专科领域数字化和自动化复杂护理数字路径的能力印象深刻，这不仅提升了患者参与度，还减轻了临床医生的行政负担。”

The solution is registered as a medical device solution further evidencing its complex workflows in the solution. The acquisition establishes a strong foundation for VitalHub in the Nordic region and strengthens our patient flow and patient engagement capabilities internationally. We believe there is a significant opportunity to accelerate Buddy Healthcare's growth through our broader customer relationships in the UK and across our global markets as it fits in perfectly.”.

该解决方案作为医疗器械解决方案进行注册，进一步证明了其工作流程的复杂性。此次收购为VitalHub在北欧地区奠定了坚实的基础，并增强了我们在国际上的患者流程管理和患者参与能力。我们相信，通过我们在英国及全球市场更广泛的客户关系，能够显著加速Buddy Healthcare的增长，因为它与我们的业务完美契合。”

“Since founding Buddy Healthcare, our mission has been to help care teams deliver more coordinated, efficient, and patient-centred care through practical digital innovation,” said Jussi Määttä, CEO of Buddy Healthcare. “We believe VitalHub is the ideal long-term home for our business, bringing deep healthcare expertise, a strong international presence, and a shared commitment to improving outcomes for providers and patients alike.

“自创立 Buddy Healthcare 以来，我们的使命始终是通过实用的数字创新，帮助护理团队提供更具协调性、更高效且以患者为中心的护理，”Buddy Healthcare 首席执行官 Jussi Määttä 表示。“我们相信，VitalHub 是我们业务的理想长期归属，它将深厚的医疗保健专业知识、强大的国际影响力以及共同致力于改善医疗服务提供者和患者成果的承诺融为一体。”

Over the past decade, we have built a leading care pathway management platform trusted by hospitals across Europe to improve patient preparation, engagement, and recovery. Together, we have an exciting opportunity to expand our impact across existing markets and introduce Buddy Healthcare's platform to a broader global audience.”.

在过去十年中，我们打造了一个领先的护理路径管理平台，深受欧洲各地医院的信赖，助力改善患者的术前准备、参与度和康复效果。携手同行，我们迎来了一个令人振奋的机遇，将在现有市场中扩大我们的影响力，并将 Buddy Healthcare 的平台推广至更广泛的全球受众。

About Buddy Healthcare

关于 Buddy Healthcare

Buddy Healthcare provides an MDR Class IIa compliant care coordination platform that streamlines perioperative and secondary care pathways. The platform digitises patient communication, assessments, and outcomes, while enabling real-time data visualisation to help care teams prioritise patients, prepare more efficiently for treatment, and support recovery and follow-up..

Buddy Healthcare 提供一个符合 MDR IIa 类标准的护理协调平台，简化围手术期和二级护理路径。该平台将患者沟通、评估和结果数字化，同时实现实时数据可视化，帮助护理团队优先处理患者、更高效地准备治疗，并支持康复和随访。

About VitalHub

关于 VitalHub

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub's comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies.

VitalHub 是一家领先的软件公司，致力于为全球健康和人类服务提供者赋能。VitalHub 的全面产品套件包括电子健康记录、运营智能和劳动力自动化解决方案，服务于英国、加拿大及其他地区的 1,300 多家客户。

The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka. For more information about VitalHub (TSX:VHI) (OTCQX:VHIBF), please visit .

公司实行稳健的双轨增长战略，既着眼于其产品套件内的有机增长机会，又积极推进积极的并购计划。VitalHub 总部位于多伦多，在全球关键地区拥有700多名员工，并在斯里兰卡设有 VitalHub 创新实验室。欲了解更多关于 VitalHub（TSX:VHI）（OTCQX:VHIBF）的信息，请访问。

www.vitalhub.com

www.vitalhub.com

and

和

LinkedIn

领英

.

。

Contact Information

联系信息

Christian Sgro, CPA, CA, CFA

克里斯蒂安·斯格罗，注册会计师（CPA），特许会计师（CA），特许金融分析师（CFA）

Head of IR and M&A Specialist

投资者关系主管兼并购专家

(365) 363-6433

(365) 363-6433

christian.sgro@vitalhub.com

christian.sgro@vitalhub.com

Dan Matlow

丹·马特洛

Chief Executive Officer, Director

首席执行官，董事

(416) 727-9061

(416) 727-9061

dan.matlow@vitalhub.com

dan.matlow@vitalhub.com

Cautionary Statement

警示声明

This news release contains 'forward-looking information' within the meaning of Canadian securities legislation. Forward-looking information generally refers to information about an issuer's business, capital, or operations that is prospective in nature, and includes future-oriented financial information about the issuer's prospective business and financial performance, and its financial position..

本新闻稿包含加拿大证券立法所定义的“前瞻性信息”。前瞻性信息通常指关于发行人业务、资本或运营的前瞻性内容，包括有关发行人预期业务和财务表现及其财务状况的未来导向财务信息。

The forward-looking information in this news release includes discussion about the terms of the acquisition, and about the business of Buddy Healthcare and its potential synergies with the Company and the potential for the international application of Buddy Healthcare’s solutions. VitalHub has made certain material assumptions in making these forward-looking statements, including but not limited to prevailing market conditions, general business, economic, competitive, political and social uncertainties, and the ability of VitalHub and Buddy Healthcare to execute and achieve their respective and combined business objectives.

本新闻稿中的前瞻性信息包括对收购条款的讨论，以及关于 Buddy Healthcare 的业务、其与本公司可能产生的协同效应，以及 Buddy Healthcare 解决方案在国际应用方面的潜力。VitalHub 在作出这些前瞻性陈述时作出了某些重大假设，包括但不限于现行市场条件、一般商业、经济、竞争、政治和社会不确定性，以及 VitalHub 和 Buddy Healthcare 执行并实现其各自及合并后业务目标的能力。

There can be no assurances that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Further, these forward-looking statements are made as of the date of this news release and, except as expressly required by applicable law, the Company assumes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise..

无法保证此类陈述将被证实为准确，因为实际结果和未来事件可能与这些陈述中预期的情况存在重大差异。因此，读者不应过度依赖前瞻性陈述。此外，这些前瞻性陈述仅截至本新闻稿发布之日作出，除非适用法律明确要求，公司不承担因新信息、未来事件或其他原因而公开更新或修订任何前瞻性陈述的义务。

Actual results may vary from the forward-looking information in this news release due to certain material risk factors. These risk factors include, but are not limited to, the assumptions made with respect to such forward-looking information, adverse market conditions, currency exchange fluctuations, the inability of VitalHub and Buddy Healthcare to successfully integrate operations, reliance on key and qualified personnel, and regulatory and other risks associated with the medical and technology industries in general.

由于某些重大风险因素，实际结果可能与本新闻稿中的前瞻性信息存在差异。这些风险因素包括但不限于：对前述前瞻性信息所作的假设、不利的市场状况、汇率波动、VitalHub 与 Buddy Healthcare 无法成功整合运营、对关键及合格人员的依赖，以及通常与医疗和科技行业相关的监管及其他风险。

The foregoing list of material risk factors and assumptions is not exhaustive. Readers, therefore, should not place undue reliance on any such forward-looking statements..

上述重大风险因素和假设的清单并非详尽无遗。因此，读者不应过度依赖任何此类前瞻性陈述。

Non-IFRS and Other Measures

非国际财务报告准则及其他指标

VitalHub uses certain financial and operating performance measures that management believes provide meaningful information in assessing the Company's underlying performance. Readers are cautioned that these measures may not have a standardized meaning prescribed by IFRS and therefore may not be comparable to similar measures presented by other issuers.

VitalHub 采用某些财务和经营绩效指标，管理层认为这些指标在评估公司基础绩效方面具有参考意义。提醒读者注意，这些指标可能不具备国际财务报告准则（IFRS）所规定的标准化含义，因此可能无法与其他发行人披露的类似指标进行直接比较。

Accordingly, non-IFRS and supplementary financial measures should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. Definitions, reconciliations, and an explanation of how the Company's non-IFRS and supplementary financial measures provide useful information to an investor are included below..

因此，不应孤立地看待非国际财务报告准则（IFRS）及补充财务指标，也不应将其作为替代根据国际财务报告准则编制的绩效指标的依据。下文载有相关定义、调节表以及关于公司非国际财务报告准则及补充财务指标如何为投资者提供有用信息的说明。

(1) Annual Recurring Revenue

(1) 年度经常性收入

Annual Recurring Revenue is a supplementary financial measure defined as annual renewable software licence fees and maintenance services. The Company defines Annual Recurring Revenue as the recurring revenue that is expected based on yearly subscriptions of the renewable software licence fees and maintenance services..

年度经常性收入是一项补充性财务指标，定义为可续订的软件许可费及维护服务的年度费用。公司将年度经常性收入定义为基于可续订软件许可费及维护服务的年度订阅所预期的经常性收入。

(2) Adjusted EBITDA

(2) 调整后息税折旧摊销前利润（Adjusted EBITDA）

Adjusted EBITDA is defined as operating income (loss) before amortization, stock-based compensation expense, interest expense, and other non-recurring items. Adjusted EBITDA is used to assess normalized cash generated on a consolidated basis. Adjusted EBITDA is also a performance measure that may be used by investors to analyze the cash generated by Buddy Healthcare.

调整后息税折旧摊销前利润（Adjusted EBITDA）定义为扣除摊销、基于股票的薪酬费用、利息支出及其他非经常性项目前的营业利润（亏损）。调整后息税折旧摊销前利润用于评估合并基础上产生的常态化现金。调整后息税折旧摊销前利润也是一项绩效指标，投资者可将其用于分析 Buddy Healthcare 产生的现金。

Adjusted EBITDA should not be interpreted as an alternative to net income (loss) and cash flow from operations as determined in accordance with IFRS or as measure of liquidity..

不应将调整后息税折旧摊销前利润（Adjusted EBITDA）解释为根据《国际财务报告准则》（IFRS）确定的净利润（亏损）和经营活动现金流量的替代指标，也不应将其作为流动性的衡量标准。